201 related articles for article (PubMed ID: 32721419)
1. Variation in the use of radiotherapy fractionation for breast cancer: Survival outcome and cost implications.
Batumalai V; Delaney GP; Descallar J; Gabriel G; Wong K; Shafiq J; Barton M
Radiother Oncol; 2020 Nov; 152():70-77. PubMed ID: 32721419
[TBL] [Abstract][Full Text] [Related]
2. The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012.
Delaney GP; Gandhidasan S; Walton R; Terlich F; Baker D; Currow D
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):266-272. PubMed ID: 27473814
[TBL] [Abstract][Full Text] [Related]
3. Adoption of hypofractionated radiation therapy for early breast cancer in private practice: the GenesisCare experience 2014–2016.
Neville K; Dreosti M; Blakey D; Latham M; Izard MA; Young S; Graham G; O'Brien P
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):127-133. PubMed ID: 31602814
[TBL] [Abstract][Full Text] [Related]
4. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.
Venigalla S; Guttmann DM; Jain V; Sharma S; Freedman GM; Shabason JE
Clin Breast Cancer; 2018 Oct; 18(5):e899-e908. PubMed ID: 29550285
[TBL] [Abstract][Full Text] [Related]
5. Patterns of palliative radiotherapy fractionation for brain metastases patients in New South Wales, Australia.
Batumalai V; Descallar J; Delaney GP; Gabriel G; Wong K; Shafiq J; Vinod SK; Barton MB
Radiother Oncol; 2021 Mar; 156():174-180. PubMed ID: 33359268
[TBL] [Abstract][Full Text] [Related]
6. Patterns of use of palliative radiotherapy fractionation for bone metastases and 30-day mortality.
Batumalai V; Descallar J; Delaney GP; Gabriel G; Wong K; Shafiq J; Vinod SK; Barton MB
Radiother Oncol; 2021 Jan; 154():299-305. PubMed ID: 33217497
[TBL] [Abstract][Full Text] [Related]
7. Introduction of ultra-hypofractionation in breast cancer: Implications for costs and resource use.
Busschaert SL; Kimpe E; Barbé K; De Ridder M; Putman K
Radiother Oncol; 2024 Jan; 190():110010. PubMed ID: 37956888
[TBL] [Abstract][Full Text] [Related]
8. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.
Jagsi R; Falchook AD; Hendrix LH; Curry H; Chen RC
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1001-9. PubMed ID: 25539365
[TBL] [Abstract][Full Text] [Related]
9. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated and hyper-hypofractionated radiation therapy in postoperative breast cancer treatment.
Fang M; Marta GN
Rev Assoc Med Bras (1992); 2020 Sep; 66(9):1301-1306. PubMed ID: 33027462
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated radiation in older women with breast cancer.
Wallace AS; Keene KS; Williams CP; Jackson BE; Pisu M; Rocque GB
Breast J; 2019 Nov; 25(6):1206-1213. PubMed ID: 31359556
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey.
Rodin D; Tawk B; Mohamad O; Grover S; Moraes FY; Yap ML; Zubizarreta E; Lievens Y
Radiother Oncol; 2021 Apr; 157():32-39. PubMed ID: 33453312
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.
Stokes WA; Abbott D; Phan A; Raben D; Lanning RM; Karam SD
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1014-1021. PubMed ID: 28721883
[TBL] [Abstract][Full Text] [Related]
14. The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation.
Meattini I; Palumbo I; Becherini C; Borghesi S; Cucciarelli F; Dicuonzo S; Fiorentino A; Spoto R; Poortmans P; Aristei C; Livi L
Radiol Med; 2022 Dec; 127(12):1407-1411. PubMed ID: 36201098
[TBL] [Abstract][Full Text] [Related]
15. Temporal impact of the publication of guidelines and randomised evidence on the adoption of hypofractionated whole breast radiotherapy for early-stage breast cancer.
Jung KYK; Shadbolt B; Rezo A
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):530-537. PubMed ID: 31087640
[TBL] [Abstract][Full Text] [Related]
16. European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer.
Meattini I; Becherini C; Boersma L; Kaidar-Person O; Marta GN; Montero A; Offersen BV; Aznar MC; Belka C; Brunt AM; Dicuonzo S; Franco P; Krause M; MacKenzie M; Marinko T; Marrazzo L; Ratosa I; Scholten A; Senkus E; Stobart H; Poortmans P; Coles CE
Lancet Oncol; 2022 Jan; 23(1):e21-e31. PubMed ID: 34973228
[TBL] [Abstract][Full Text] [Related]
17. Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation.
Shah C; Ward MC; Tendulkar RD; Cherian S; Vicini F; Singer ME
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):397-402. PubMed ID: 30253236
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionation: The standard for external beam breast irradiation.
Brunt AM; Haviland JS
Breast; 2023 Jun; 69():410-416. PubMed ID: 37120889
[TBL] [Abstract][Full Text] [Related]
19. Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.
Jagsi R; Griffith KA; Vicini FA; Abu-Isa E; Bergsma D; Bhatt A; Dilworth JT; Dominello M; Franklin S; Heimburger DK; Kaufman I; Kocheril PG; Kretzler AE; Paximadis P; Radawski JD; Walker EM; Pierce L
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):853-860. PubMed ID: 34718094
[TBL] [Abstract][Full Text] [Related]
20. Can the Adoption of Hypofractionation Guidelines Expand Global Radiotherapy Access? An Analysis for Breast and Prostate Radiotherapy.
Irabor OC; Swanson W; Shaukat F; Wirtz J; Mallum AA; Ngoma T; Elzawawy A; Nguyen P; Incrocci L; Ngwa W
JCO Glob Oncol; 2020 Apr; 6():667-678. PubMed ID: 32343628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
